Treatment of Heart Failure with Sodium-glucose Cotransporter Type 2 Inhibitors
Heart failure is a chronic disease that affects millions of people worldwide and is a leading cause of death. Sodium-glucose cotransporter type 2 inhibitors are a new class of drugs that have demonstrated cardiovascular benefits in patients with type 2 diabetes. The aim of the research was to gain i...
Saved in:
| Main Authors: | Riber Fabián Donoso Noroña, Nairovys Gómez Martínez, Adisnay Rodríguez Plasencia |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2024-09-01
|
| Series: | Medisur |
| Subjects: | |
| Online Access: | http://medisur.sld.cu/index.php/medisur/article/view/45262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impacto en los desenlaces intrahospitalarios con el inicio de un inhibidor del cotransportador de sodio-glucosa 2 (iSGLT2) en insuficiencia cardíaca aguda descompensada
by: Wilfredo A. Rivera-Martínez, et al.
Published: (2025-04-01) -
Registro de insuficiencia cardíaca agudamente descompensada: MALEOS
by: Martín Ocampo-Posada, et al.
Published: (2025-07-01) -
Insuficiencia cardíaca descompensada en un solo centro de un país latinoamericano: hallazgos de los primeros 1595 casos en el registro ICARUS
by: Lyda Z. Rojas, et al.
Published: (2025-01-01) -
Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion
by: Carolina Gomes, et al.
Published: (2025-05-01) -
Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion
by: Carolina Gomes, et al.
Published: (2025-05-01)